Broderick Brian C lessened its holdings in shares of Johnson & Johnson (NYSE:JNJ) by 6.9% during the 3rd quarter, HoldingsChannel reports. The firm owned 77,821 shares of the company’s stock after selling 5,738 shares during the period. Johnson & Johnson makes up about 3.7% of Broderick Brian C’s holdings, making the stock its biggest position. Broderick Brian C’s holdings in Johnson & Johnson were worth $10,117,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also modified their holdings of the company. Hemenway Trust Co LLC raised its holdings in Johnson & Johnson by 2.0% in the third quarter. Hemenway Trust Co LLC now owns 123,000 shares of the company’s stock valued at $15,991,000 after acquiring an additional 2,398 shares in the last quarter. Eagle Ridge Investment Management raised its holdings in Johnson & Johnson by 3.5% in the third quarter. Eagle Ridge Investment Management now owns 27,522 shares of the company’s stock valued at $3,578,000 after acquiring an additional 928 shares in the last quarter. FinTrust Investment Advisory Services LLC acquired a new stake in Johnson & Johnson in the third quarter valued at approximately $886,000. Paragon Capital Management Ltd raised its holdings in Johnson & Johnson by 10.2% in the third quarter. Paragon Capital Management Ltd now owns 16,371 shares of the company’s stock valued at $2,128,000 after acquiring an additional 1,520 shares in the last quarter. Finally, Patriot Financial Group Insurance Agency LLC raised its holdings in Johnson & Johnson by 49.3% during the third quarter. Patriot Financial Group Insurance Agency LLC now owns 5,313 shares of the company’s stock worth $709,000 after purchasing an additional 1,754 shares in the last quarter. 65.70% of the stock is currently owned by institutional investors and hedge funds.

Johnson & Johnson (JNJ) opened at $144.14 on Wednesday. Johnson & Johnson has a 1 year low of $110.76 and a 1 year high of $145.68. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. The stock has a market cap of $387,230.00, a P/E ratio of 25.02, a PEG ratio of 2.67 and a beta of 0.80.

Johnson & Johnson (NYSE:JNJ) last posted its quarterly earnings data on Tuesday, October 17th. The company reported $1.90 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.10. Johnson & Johnson had a net margin of 21.28% and a return on equity of 27.38%. The firm had revenue of $19.65 billion for the quarter, compared to analyst estimates of $19.29 billion. During the same period last year, the firm posted $1.68 EPS. Johnson & Johnson’s quarterly revenue was up 10.3% on a year-over-year basis. research analysts predict that Johnson & Johnson will post 7.28 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 13th. Investors of record on Tuesday, February 27th will be given a $0.84 dividend. The ex-dividend date of this dividend is Monday, February 26th. This represents a $3.36 dividend on an annualized basis and a yield of 2.33%. Johnson & Johnson’s dividend payout ratio (DPR) is 58.33%.

A number of analysts have weighed in on the stock. Royal Bank of Canada reissued a “buy” rating on shares of Johnson & Johnson in a report on Tuesday. Citigroup raised their price objective on shares of Johnson & Johnson from $140.00 to $149.00 and gave the stock a “buy” rating in a report on Monday, October 23rd. Vetr cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating and set a $147.40 price objective on the stock. in a report on Monday. Zacks Investment Research cut shares of Johnson & Johnson from a “buy” rating to a “hold” rating in a report on Tuesday, December 12th. Finally, BMO Capital Markets raised their price objective on shares of Johnson & Johnson to $161.00 and gave the stock an “outperform” rating in a report on Tuesday, December 12th. Four analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have issued a buy rating to the company. Johnson & Johnson has a consensus rating of “Hold” and an average price target of $145.52.

TRADEMARK VIOLATION NOTICE: “Broderick Brian C Sells 5,738 Shares of Johnson & Johnson (JNJ)” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this piece on another website, it was illegally stolen and reposted in violation of U.S. & international copyright legislation. The original version of this piece can be viewed at https://www.watchlistnews.com/broderick-brian-c-sells-5738-shares-of-johnson-johnson-jnj/1800925.html.

Johnson & Johnson Profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.

Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with Analyst Ratings Network's FREE daily email newsletter.